GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Arzneiwerk AG VIDA (XTER:TLIK) » Definitions » Total Equity

Arzneiwerk AG VIDA (XTER:TLIK) Total Equity : €-4.97 Mil (As of Sep. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Arzneiwerk AG VIDA Total Equity?

Arzneiwerk AG VIDA's total equity for the quarter that ended in Sep. 2024 was €-4.97 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Arzneiwerk AG VIDA Total Equity Historical Data

The historical data trend for Arzneiwerk AG VIDA's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arzneiwerk AG VIDA Total Equity Chart

Arzneiwerk AG VIDA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.33 0.01 1.61 0.38 -1.51

Arzneiwerk AG VIDA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.77 -1.51 -5.24 -5.70 -4.97

Arzneiwerk AG VIDA Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Arzneiwerk AG VIDA's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=3.304-3.304
=0.00

Arzneiwerk AG VIDA's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=12.148-17.114
=-4.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arzneiwerk AG VIDA Total Equity Related Terms

Thank you for viewing the detailed overview of Arzneiwerk AG VIDA's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Arzneiwerk AG VIDA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Arzneiwerk AG VIDA (XTER:TLIK) » Definitions » Total Equity
Comparable Companies
XTER:VOS FRA:EUK3 XTER:MLL HAM:NEP XTER:HHFA MCK COR CAH SHSE:601607 HSIC HKSE:01099 SHSE:600332 MIL:AMP XSWX:GALE NZSE:EBO SHSE:600511 TSE:7459 TSE:2784 ASX:SIG TSE:9987
Traded in Other Exchanges
TLIK:Germany
Address
Ordensmeisterstrasse 15-16, Berlin, DEU, 12099
Website
https://www.arzneiwerk.ag
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe which usually includes high-priced drugs for chronic, complex, or rare diseases such as oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases.

Arzneiwerk AG VIDA Headlines

No Headlines